The Food and Drugs Association is known around the world to take high safety measures and thorough procedures where the testing and assessment of any type of drug and or other treatments are concerned. The FDA is also known to first test and check up on all medications that are made before they are sent into the market and released for public use and Salbutamol - Ventolin & Proventil was no exception. The FDA specifically will check up on medications and their addictive qualities and will allow their dosage and availability to be in accordance to safety.

The FDA is very keen on re testing all medications that are in the market so as to set an up to date standard for the future production of those medications. The FDA is especially concerned with the clinical use of several drugs and has allowed the release of Salbutamol - Ventolin & Proventil in the US, Australia and UK under controlled prescription based sale. The drug was first put through a series of clinical tests to check the chemical content and its effect on the patient. The manufacturers of the inhaler are also then given a thorough investigation and checked for up to date equipment and all other standards. The sale of these medications is strictly to be done on the basis of a registered prescription and also on the basis of prior prescription. Salbutamol - Ventolin & Proventil has been checked for any extra content which may be addictive in nature.